Eliminating silos of data into a comprehensive industrial data fabric enables reshaping the data landscape to provide aggregated, contextualized data for digital transformation initiatives for pharmaceutical & biotech manufacturers.
If there’s one thing that has been repeatedly proven true in the life sciences industry, it’s that automation drives success. After all, automation leads to repeatability, fewer mistakes, higher safety, and faster outcomes. This high success rate for automation in...
David Zhang joins podcast host Jim Cahill to discuss digitalization efforts among pharmaceutical & biotech manufacturers, and the important role that real-time scheduling plays in bringing these therapies to market in a timely manner.
We talk a lot about cybersecurity in the OT space. Cybersecurity has always posed a unique challenge for OT technologies, for a number of reasons. Often, OT teams are dealing with legacy technology that was never designed to be cybersecure and doesn’t operate in a...
The life sciences industry is rapidly advancing with innovations in personalized medicine, digital health, and biopharmaceuticals. To keep up with the demand for quality, speed, and sustainability, manufacturers are adopting automation and digital technologies. Key tools like smart sensors and advanced measurement devices enable real-time monitoring and precise control throughout the manufacturing process, resulting in greater efficiency and faster delivery of therapies. These technologies also assist in maintaining quality and compliance by providing accurate measurements and early issue detection. The integration of these data-driven solutions optimizes operations, enhances sustainability, and improves reliability, paving the way for a future where pharmaceutical manufacturing is more connected and intelligent, ultimately delivering safer and more effective medicines globally.
There exists an interesting tension in the life sciences industry; while people have access to more treatments for more maladies than at any other time in human history, there is also increasing pressure to deliver new, innovative treatments. For evidence, simply look...
It’s hard to discuss the life sciences today without talking about advanced therapeutics and personalized medicine. We are currently in a period of massive innovation that will reshape the delivery of medicine for decades to come. Where once pharmaceutical companies...
Highlights on a path to more connected sites, systems, and the enterprise. This Emerson Exchange session featured discussions involving foundational connectivity, module enhancements, a scalable data fabric, integrated applications, and an intelligent platform specific to the Life Sciences sector.
Flow measurement may not always make headlines, but for industries like oil and gas, chemical manufacturing, and life sciences, it’s the cornerstone of operational excellence. I recently had the pleasure of joining Len Vermillion on the Control Amplified podcast to...
Advanced automation technologies offer scalable solutions. These range from wireless acoustic transmitters that detect steam trap leaks in real time to predictive analytics that flag failing batches before they waste precious energy and materials. Even better, many of these tools offer short ROI timelines—sometimes within months.
Emerson’s Jordan Johnson & Rachel Wright join Jim Cahill in this podcast to discuss challenges in the Life Sciences sector and the role of Emerson Life Savers serve in collaborating closely with them to address and overcome these challenges.
Emerson’s Bruce Greenwald, Christian Berg, and David Gray collaborated to present “Solutions for Advanced Therapeutics” at the Emerson Exchange 2025 Conference.
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to stay up to date on the latest news, events and innovations that will help you face and solve your toughest challenges.
Just post a link to the entry and send us a quick note so we can share your work. Thank you very much.
Our Global Community
Emerson Exchange 365
The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.